To hear about similar clinical trials, please enter your email below
Trial Title:
Does Continuous Vital Sign Monitoring Increase Investigations and Interventions in Complication-free Patients?
NCT ID:
NCT06361862
Condition:
Cancer
Chronic Obstructive Pulmonary Disease
Surgery-Complications
Conditions: Official terms:
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Diagnostic
Masking:
Double (Participant, Investigator)
Intervention:
Intervention type:
Device
Intervention name:
Active alarms from WARD software
Description:
Wireless continuous vital sign monitoring with real time staff alerts
Arm group label:
active alarms
Summary:
This aim of this study is to investigate whether active alerts during CVSM result in an
increased number of diagnostic tests and treatments in complication free patients,
hypothesizing that more interventions are performed in the CVSM-group than standard of
care (EWS) group.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- • Patients from WARD - RCT.
Exclusion Criteria:
-
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
Accepts Healthy Volunteers
Locations:
Facility:
Name:
Eske Kvanner Aasvang
Address:
City:
Copenhagen
Zip:
2100
Country:
Denmark
Status:
Recruiting
Contact:
Last name:
Eske K Aasvang, M.D., DMSci
Phone:
+4526232076
Email:
eske.kvanner.aasvang.01@regionh.dk
Start date:
January 1, 2024
Completion date:
April 1, 2025
Lead sponsor:
Agency:
Rigshospitalet, Denmark
Agency class:
Other
Collaborator:
Agency:
Bispebjerg Hospital
Agency class:
Other
Source:
Rigshospitalet, Denmark
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06361862
